The high-level expression of gene sets associated with ESC identity, such as Nanog, Oct4, Sox2, and Myc targets, and the underrepresentation of the expression of Polycomb target genes were observed in poorly differentiated tumors of various origins (breast cancer, glioblastoma, and bladder carcinoma). This evidence concerns the gene NANOG and urinary bladder carcinoma.